Works by Lin-Di Jiang


Results: 13
    1
    2
    3
    4
    5

    A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis

    Published in:
    Clinical Rheumatology, 2013, v. 32, n. 1, p. 99, doi. 10.1007/s10067-012-2096-z
    By:
    • Chen, Xiao-Xiang;
    • Dai, Qing;
    • Huang, An-Bin;
    • Wu, Hua-Xiang;
    • Zhao, Dong-Bao;
    • Li, Xing-Fu;
    • Hu, Shao-Xian;
    • Yang, Nan-Ping;
    • Tao, Yi;
    • Xu, Jian-Hua;
    • Jiang, Lin-Di;
    • Bao, Chun-De
    Publication type:
    Article
    6
    7
    8

    Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE.

    Published in:
    Advances in Therapy, 2021, v. 38, n. 1, p. 772, doi. 10.1007/s12325-020-01572-y
    By:
    • Li, Zhan-Guo;
    • Hu, Jian-Kang;
    • Li, Xiang-Pei;
    • Yang, Yue;
    • Li, Xing-Fu;
    • Xu, Jian-Hua;
    • Zhang, Xiao;
    • Xu, Jian;
    • Bao, Chun-De;
    • He, Dong-Yi;
    • Li, Zhi-Jun;
    • Wang, Guo-Chun;
    • Zuo, Xiao-Xia;
    • Liu, Yi;
    • Xiao, Zheng-Yu;
    • Chen, Jin-Wei;
    • Xin, Xia-Fei;
    • Li, Jing-Yang;
    • Jiang, Lin-Di;
    • Liu, Meng-Ru
    Publication type:
    Article
    9
    10
    11
    12
    13